Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis
ConclusionThe benefit-risk profile of NOACs compared to VKAs was preserved in AF patients using P-gp/CYP3A4 inhibitors, including amiodarone.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Amiodarone | Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Coumadin | Gastroenterology | Heart | Stroke | Study | Vitamin K | Vitamins | Warfarin